ZBD

Zhitong · Sep 19, 2025 at 03:49 AM

ZBD's controlling shareholder passively reduced its holdings due to bond conversion, with shareholding dropping to 59.87%

Zhitong · Sep 11, 2025 at 03:54 AM

ZBD Pharmaceuticals' shareholder Huzhou Saihan reduced its holdings, bringing its stake down to 5%

Zhitong · Aug 27, 2025 at 03:50 AM

ZBD: Net profit loss of 78.2899 million yuan in the first half of 2025

Zhitong · Aug 20, 2025 at 03:14 AM

ZBD: The conversion price of the convertible bonds held by the controlling shareholder will be adjusted from RMB 13.35 per share to RMB 12.35 per share

Zhitong · Jun 25, 2025 at 05:11 AM

ZBD: The approval notice for the listing application of fumaric acid lupatadine as a chemical raw material drug has been obtained

Zhitong · Jun 22, 2025 at 10:33 PM

Huafu Securities: The Chinese medicine sector is expected to improve quarter by quarter in Q2-3 of 2025. Pay attention to the possibility of including innovative drug varieties in this year's medical insurance